Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
Evofem Biosciences

Evofem Biosciences

EvoFem is a biotech company that developes reproductive and contraceptive care products for women on a global scale.

Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.

Timeline

April 28, 2021
Evofem Biosciences announces that two new data sets from its Phase 3 AMPOWER trial evaluating Phexxi® will be presented at the 2021 American College of Obstetricians and Gynecologists Annual Clinical and Scientific Meeting .
February 4, 2021
Evofem Biosciences and NCODA announce collaboration to educate oncology community about Phexxi®, A Non-Hormonal Birth Control Option for Women with Cancer.

Funding Rounds

Patents

Further Resources

Title
Author
Link
Type
Date

News

Title
Author
Date
Publisher
Description
Evofem Biosciences, Inc.
May 21, 2021
www.prnewswire.com:443
/PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM) today announced the closing of its previously announced underwritten public offering of 50 million...
Evofem Biosciences, Inc.
May 18, 2021
www.prnewswire.com:443
/PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM) today announced the pricing of its previously announced underwritten public offering of 50,000,000...
Evofem Biosciences, Inc.
April 28, 2021
www.prnewswire.com:443
/PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced that two new data sets from its Phase 3 AMPOWER trial evaluating Phexxi® (lactic acid,...
Brandon May
March 25, 2021
BioSpace
Several new initial public offering (IPO) announcements have been made by international and U.S.-based biopharmaceutical and biotechnology companies in the past couple of days.
Evofem Biosciences, Inc.
March 4, 2021
www.prnewswire.com:443
/PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM), a commercial stage biopharmaceutical company, today reported financial results for the three- and...
SHOW MORE

References

Golden logo
By using this site, you agree to our Terms & Conditions.